Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes    Leukemias    Solid Tumors    Cancer-Prone    Deep Insight    Case Reports    Journals   Portal    Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
    

Familial chronic lymphocytic leukaemia

by Dr Martin Yuille
Institute of Cancer Research Sutton

Literature reports on chronic lymphocytic leukaemia (CLL) that show both an elevated familial relative risk and familial clustering suggest there is value in conducting a genome-wide linkage search on CLL families. Our current aim is to ascertain families with CLL and to collect blood samples in order to perform a genetic linkage study.

Background

Approximately 1.3% of males and 1% of females in Europe and North America develop leukaemia. CLL is the most common of its subtypes, constituting about 30% of all cases. Its incidence rate increases logarithmically from age 35 and has a median age of onset of 64 years. No single cytogenetic abnormality or gene mutation is found in all CLL cases. However, activation of each of the oncogenes BCL1, BCL2 and BCL3 has been reported in some cases after detection of cytogenetic abnormalities, as has mutation in tumour suppressor genes including those associated with the mutator phenotype and p53 . A putative tumour suppressor locus has been identified on chromosome 13q14.

A number of case-control and cohort studies have examined the cancer risks associated with a family history of lymphoproliferative disorders, including CLL (Table 1). These studies showed an elevated risk of lymphoproliferative disorders in relatives. Although no study has systematically examined the incidence of leukaemia by specific subtype in cases and relatives, there is evidence suggesting that the familial risk of leukaemia is greater than the risk of all lymphoproliferative disorders. In the cohort study reported by Goldgar et al using the Utah population database, a 6-fold increase in risk was seen in relatives of patients with lymphocytic leukaemia. This database comprises over 1.4 million records on a population with normal levels of inbreeding that is genetically representative of a Northern European population.

Study Cases Relatives Obs Exp
Radovanovic et al., 1994 Chronic lymphocytic leukaemiaLeukaemia - First and second degree7/1300/130
Pottern et al., 1991Chronic lymphocytic leukaemiaLeukaemia - Parents and siblings13/23730/1207
Linet et al., 1989Chronic lymphocytic leukaemiaLeukaemia - Parents and siblings25/34210/342
Cartwright et al., 1987Chronic lymphocytic leukaemiaLymphocytic leukaemia - All blood5/3302/559
Giles et al., 1984Lymphoproliferative disordersLympho-proliferative disorders - First degree 3510.3
Gunz et al., 1975LeukaemiaLeukaemia - First degree166.61
Goldgar et al., 1994Lymphocytic leukaemiaLymphocytic leukaemia - First degree183.6

Table 1: Familial leukaemia risks

Case reports

There is no doubt from literature reports over 7 decades that multiple cases of CLL do occur in families. Two of these are illustrated in Figures 1 and 2. Both are consistent explicitly or implicitly with vertical transmission of an autosomal trait over three generations. In Figure 1, the absence of recorded CLL in the first two generations is consistent with incomplete penetrance.

Figure 1. Adapted from McPhedran et al - filled symbols indicate a diagnosis of CLL

Figure 2. Adapted from Furbetta et al - filled symbols indicate a diagnosis of CLL

Although early reports on familial CLL were published before B-cells had been described, most of the diagnoses are likely to be accurate. This is because the specific morphology of mature B-cell CLL makes diagnosis comparatively easy and the generally indolent course of the disease contrasts markedly with the other leukaemias. We have identified reports that describe over 80 pedigrees which show clustering of CLL and, sometimes, other lymphoproliferative disorders. Some of this literature has been reviewed . Of these 80 pedigrees, over a quarter are multigenerational CLL families with up to four generations, thus illustrating vertical transmission of CLL consistent with an autosomal dominant mode of inheritance. The majority of families comprise sibs. This is not surprising: CLL usually has an indolent course and may be asymptomatic for many years, yet it also has a late onset. It has been suggested that even striking clusters of common cancers could be due to ascertainment bias. This is, however, statistical fallacy. For example, we have identified reports of 10 sibships with three of more affecteds, yet a family with 3 affected sibs would be expected to occur by chance about every 1,000 years.

Analysis of these reports [26] has also indicated a mean decline in age of onset of 21 years (SE = 4.1y) (P = 0.001) between the affected in the parental generation and the affected offspring as well as a reduced cumulative disease-free survival period for the offspring. Anticipation is now known to arise in a dozen instances from single gene defects associated, variously, with dominant or recessive modes of inheritance.

Identification of a familial CLL gene would significantly help research into the molecular pathology and aetiology of CLL. Earlier diagnosis of CLL and new approaches to therapy should also follow identification of a gene or genes.

Current progress

In 1996 we began collecting detailed family histories from 130 patients with CLL registered at the Royal Marsden Hospital under the care of D.C. In order to extend the study, the MRC Adult Leukaemia Working Party gave us permission to identify CLL patients in MRC trials and contact their consultants (DC is the MRC trials co-ordinator). Of the 1402 patients with CLL registered in the CLL trials, we have contacted and collected family history information on 250 (June 1997). We have identified 20 families with at least two CLL cases. In most of the potentially informative families, the affecteds are siblings. We are pursuing a further 39 families.

We initiated this spring an International Co-operative Group on Familial CLL under the auspices of the International Workshop on CLL with a successful satellite meeting of IWCLL. All members of IWCLL in 32 nations overseas have been contacted and many have expressed an interest in contributing. So far, around 20 overseas CLL families have been identified and blood samples are being collected.

We have confirmed the finding of anticipation in our families and we have published data that does not support the claim that germline mutations in the Ataxia Telangiectasia confer a particular risk of CLL.


International effort

The identification of sufficient CLL families to be able successfully to perform a genetic linkage study to find the CLL gene is a major task. With support from the Medical Research Council in the UK and from the International Workshop on CLL, the Co-ordinating Centre based at the Institute of Cancer Research and the Royal Mrsden NHS Trust Hospital in London has been able to accrue families from around the world on a collaborrative basis. For example, haematologists from 9 countries contributed families to a paper testing a candidate gene, ATM. More detailed genetic approaches will become possible as the numbers of families contributed increases.
Clinicians who identify CLL families (i.e. families with more than one affected individual) are encouraged to advise the Co-ordinating Centre.

Contact:
M. R. Yuille MA PhD
Academic Department of Haematology and Cytogenetics
Institute of Cancer Research
15 Cotswold Road
SUTTON Surrey SM2 5NG UK

Telephone: 020 8 722 4666
Fax:<020 8 643 6940
E-mail: myuille@icr.ac.uk

OR

Prof Daniel Catovsky DSc(Med) FRCPath FRCP FMedSci
Academic Department of Haematology and Cytogenetics
Royal Marsden NHS Trust Hospital
Fulham road
London SW3 6JJ

Telephone: 020 7 808 2880/2875
Fax: 020 7 351 6420

Bibliography

Cancer Statistics Review 1973-90, National Cancer Institute, NIH Pub No. 93-2789. Devesa, eds.1993
Miller BA, Ries LAG, Hankey BF, Kosary CL Harras A, SS
 
Biology of chronic lymphocytic leukemia.
Gale RP, Foon KA
Seminars in hematology. 1987 ; 24 (4) : 209-229.
PMID 3317850
 
The epidemiology of Chronic Lymphocytic Leukemia in Chronic Lymphocytic Leukaemia eds. Polliack A and D. Catovsky. Harwood Academic Publishers Chur, Switzerland.1988
Linet MS, WA Blattner
 
Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia.
Oscier DG
Blood reviews. 1994 ; 8 (2) : 88-97.
PMID 7950479
 
Mutator phenotype in a subset of chronic lymphocytic leukemia.
Gartenhaus R, Johns MM 3rd, Wang P, Rai K, Sidransky D
Blood. 1996 ; 87 (1) : 38-41.
PMID 8547666
 
The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene.
Hawthorn LA, Chapman R, Oscier D, Cowell JK
Oncogene. 1993 ; 8 (6) : 1415-1419.
PMID 8502470
 
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH
Journal of the National Cancer Institute. 1994 ; 86 (21) : 1600-1608.
PMID 7932824
 
Demographic and genetic application of computerized record linking: the Utah Mormon genealogy
Jorde LB, MH Skolnick
Information et Sciences Humaines. 1981 ; 56 (57) : 105-117.
 
Genetic distances between the Utah Mormons and related populations.
McLellan T, Jorde LB, Skolnick MH
American journal of human genetics. 1984 ; 36 (4) : 836-857.
PMID 6591796
 
Cancer mortality of family members of patients with chronic lymphocytic leukemia.
Radovanovic Z, Markovic-Denic L, Jankovic S
European journal of epidemiology. 1994 ; 10 (2) : 211-213.
PMID 7813700
 
Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma.
Pottern LM, Linet M, Blair A, Dick F, Burmeister LF, Gibson R, Schuman LM, Fraumeni JF Jr
Leukemia research. 1991 ; 15 (5) : 305-314.
PMID 2046383
 
Familial cancer history and chronic lymphocytic leukemia. A case-control study.
Linet MS, Van Natta ML, Brookmeyer R, Khoury MJ, McCaffrey LD, Humphrey RL, Szklo M
American journal of epidemiology. 1989 ; 130 (4) : 655-664.
PMID 2773914
 
Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire.
Cartwright RA, Bernard SM, Bird CC, Darwin CM, O'Brien C, Richards ID, Roberts B, McKinney PA
British journal of cancer. 1987 ; 56 (1) : 79-82.
PMID 3304389
 
Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: occupational and familial aspects.
Giles GG, Lickiss JN, Baikie MJ, Lowenthal RM, Panton J
Journal of the National Cancer Institute. 1984 ; 72 (6) : 1233-1240.
PMID 6587145
 
Familial leukaemia: a study of 909 families.
Gunz FW, Gunz JP, Veale AM, Chapman CJ, Houston IB
Scandinavian journal of haematology. 1975 ; 15 (2) : 117-131.
PMID 1188315
 
Patterns of familial leukemia. Ten cases of leukemia in two interrelated families.
McPhedran P, Heath CW Jr, Lee J
Cancer. 1969 ; 24 (2) : 403-407.
PMID 5256260
 
Hereditary chronic lymphatic leukemia
Furbetta D, P Solinas
Proc. Sec Intern. Congr Hum Genet.(1961). 1963 ; 2 : 1078-1079.
 
Not Available
GUASCH J
Le Sang. 1954 ; 25 (4) : 384-421.
PMID 13195546
 
Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease.
Conley CL, Misiti J, Laster AJ
Medicine. 1980 ; 59 (5) : 323-334.
PMID 7001171
 
The Hereditary Basis of Human Leukemia. In Leukemia (6th edition) edited by Henderson E.S., Lister T.A. and M.F. Greaves. W.B. Saunders Co. London 1996
Taylor GM, JM Birch
 
Anticipation in familial leukemia.
Horwitz M, Goode EL, Jarvik GP
American journal of human genetics. 1996 ; 59 (5) : 990-998.
PMID 8900225
 
Anticipation in familial chronic lymphocytic leukaemia.
Yuille MR, Houlston RS, Catovsky D
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1998 ; 12 (11) : 1696-1698.
PMID 9823943
 
Ataxia telangiectasia gene mutations and chronic lymphocytic leukaemia.
Bevan S, Yuille MR, Marossy A, Catovsky D, Houlston RS
Lancet. 1999 ; 353 (9154) : page 753.
PMID 10073541
 
Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia.
Bevan S, Catovsky D, Marossy A, Matutes E, Popat S, Antonovic P, Bell A, Berrebi A, Gaminara E, Quabeck K, Ribeiro I, Mauro FR, Stark P, Sykes H, van Dongen J, Wimperis J, Wright S, Yuille MR, Houlston RS
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1999 ; 13 (10) : 1497-1500.
PMID 10516748
 
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.
Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA, Taylor AM
Lancet. 1999 ; 353 (9146) : 26-29.
PMID 10023947
 
Written1999-10Martin Yuille
Department of Haematology, Cytogenetics Institute of Cancer Research, 15 Cotswold Road, SUTTON Surrey SM2 5NG, UK

Citation

This paper should be referenced as such :
Yuille, M
Familial chronic lymphocytic leukaemia
Atlas Genet Cytogenet Oncol Haematol. 1999;3(4):222-224.
Free journal version : [ pdf ]   [ DOI ]
On line version : http://AtlasGeneticsOncology.org/Deep/FamilCLLID20009.htm

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Sep 26 12:38:21 CEST 2017


Home   Genes    Leukemias    Solid Tumors    Cancer-Prone    Deep Insight    Case Reports    Journals   Portal    Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.